Literature DB >> 31000955

Prevalence, Demographic Profile, and Psychological Aspects of Epilepsy in North-Western India: A Community-Based Observational Study.

Ashok Panagariya1, Bhawna Sharma2, Parul Dubey3, Vipin Satija4, Monika Rathore5.   

Abstract

AIMS: This study was undertaken to determine the prevalence of active epilepsy, assess the sociodemographic profile, and psychological aspects of epilepsy in the Jaipur district of Rajasthan, India.
METHODS: We conducted a community-based, cross-sectional observational study covering both rural (n = 165,660) and urban (n = 179,142) populations of Jaipur district using a house-to-house survey. An adapted, pre-designed World Health Organization screening questionnaire was used to identify the cases. Those confirmed by neurologists as true seizures were included in the study. Cases were classified as per the International League against Epilepsy recommendation. Global Mental Health Assessment Tool electronic questionnaire was used to analyze psychological aspects of cases. The caregivers of the patients participated in the knowledge, attitude, and practice (KAP) survey.
RESULTS: A total of 380 patients (258 men, 122 women) were identified with active epilepsy. The estimated prevalence of active epilepsy was 1.1/1,000 population and 71% of cases belonged to low socioeconomic classes. Primary treatment gap was documented in 18.8% of cases in our study, 38% of cases were non-compliant to treatment with poorer compliance in those on pol-therapy, 76% had some psychiatric disorder, anxiety and depression being the commonest, and positive family history of epilepsy was found in 4.7%. KAP survey revealed that only 15% of the respondents believed that epilepsy is non-curable, 74% denied its infectious nature, 26% believed that epilepsy occurs due to past sins, and 81% said that they would not marry persons with epilepsy.
CONCLUSION: A relatively low prevalence (1.1/1,000) of active epilepsy and a smaller primary treatment gap (18.8%) was found in our study population. Almost three-fourth of cases had an associated psychological problem, Though caregivers were aware of the nature of disease, majority would not prefer to marry a person suffering from epilepsy.

Entities:  

Keywords:  Epilepsy; India; Jaipur; Knowledge attitude; Prevalence; Rajasthan; Seizure

Year:  2018        PMID: 31000955      PMCID: PMC6470329          DOI: 10.1159/000487072

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


  30 in total

1.  Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology.

Authors:  W T Blume; H O Lüders; E Mizrahi; C Tassinari; W van Emde Boas; J Engel
Journal:  Epilepsia       Date:  2001-09       Impact factor: 5.864

2.  The Global Mental Health Assessment Tool--Primary Care Version (GMHAT/PC). Development, reliability and validity.

Authors:  Vimal K Sharma; Peter Lepping; Anthony G P Cummins; John R M Copeland; Rashmi Parhee; Patricia Mottram
Journal:  World Psychiatry       Date:  2004-06       Impact factor: 49.548

Review 3.  Epidemiology of epilepsy in India.

Authors:  N E Bharucha
Journal:  Epilepsia       Date:  2003       Impact factor: 5.864

4.  Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.

Authors:  Alison Krentel; Peter Fischer; Paul Manoempil; Taniawati Supali; Gérard Servais; Paul Rückert
Journal:  Trop Med Int Health       Date:  2006-11       Impact factor: 2.622

5.  Prevalence and pattern of epilepsy in India.

Authors:  R Sridharan; B N Murthy
Journal:  Epilepsia       Date:  1999-05       Impact factor: 5.864

6.  Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies.

Authors:  M Placencia; J W Sander; S D Shorvon; R H Ellison; S M Cascante
Journal:  Brain       Date:  1992-06       Impact factor: 13.501

7.  Prevalence, knowledge, attitude, and practice of epilepsy in Kerala, South India.

Authors:  K Radhakrishnan; J D Pandian; T Santhoshkumar; S V Thomas; T D Deetha; P S Sarma; D Jayachandran; E Mohamed
Journal:  Epilepsia       Date:  2000-08       Impact factor: 5.864

Review 8.  A systematic review of the epidemiology of epilepsy in Arab countries.

Authors:  Hani T S Benamer; Donald G Grosset
Journal:  Epilepsia       Date:  2009-04-06       Impact factor: 5.864

Review 9.  The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies.

Authors:  Caroline K Mbuba; Anthony K Ngugi; Charles R Newton; Julie A Carter
Journal:  Epilepsia       Date:  2008-06-13       Impact factor: 5.864

10.  Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas.

Authors:  M Gourie-Devi; G Gururaj; P Satishchandra; D K Subbakrishna
Journal:  Neuroepidemiology       Date:  2004-08-05       Impact factor: 3.282

View more
  4 in total

Review 1.  Global Health and Epilepsy: Update and Future Directions.

Authors:  Mary C Spiciarich; Jane R von Gaudecker; Laura Jurasek; Dave F Clarke; Jorge Burneo; Jorge Vidaurre
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-01       Impact factor: 5.081

2.  Impact of COVID-19 on People Suffering with Epilepsy.

Authors:  Rajendra K Sureka; Vikas Gaur; Medha Gupta
Journal:  Ann Indian Acad Neurol       Date:  2020-10-07       Impact factor: 1.383

3.  Clinical characteristics of epilepsy in resource-limited communities in Punjab, Northwest India.

Authors:  Gagandeep Singh; Sachi Singhal; Suman Sharma; Birinder S Paul; Namita Bansal; Anurag Chaudhary; Sarit Sharma; Rajnder K Bansal; Jatinder S Goraya; Raj K Setia; Josemir W Sander
Journal:  Epilepsia Open       Date:  2020-11-01

4.  Effect of cinnamaldehyde on Cav-1 and Survivin expression in epilepsy: A protocol of systematic review and meta-analysis.

Authors:  Jia-Nan Yu; Cai-Fang Yue; Ke-Jian Wang; Nan-Nan Chi; Xin Li
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.